UMass Memorial to start administering COVID antibody treatments
Photo/Grant Welker
The Memorial Campus of UMass Memorial Medical Center.
UMass Memorial Medical Center in Worcester is partnering with the U.S. Department of Health and Human Services to expand access to the COVID-19 monoclonal antibody treatments, according to a press announcement Wednesday.
Starting July 14, the center will start administering the therapies at its Hahnemann campus in Worcester for people who have tested positive for COVID-19 and are at high risk of developing severe illness.
Patients must call the center to confirm eligibility and book an appointment. A mobile unit on the hospital grounds devoted to administering the treatment will be open from 8:30 a.m. to 4:30 p.m.
Studies have shown the antibody treatment can significantly lessen the severity of the disease and prevent hospitalization, according to the press release. It is a one-time, intravenous infusion and must be administered within 10 days of showing symptoms to be most effective.
The medical center will host an event on-site announcing the new treatment clinic, with a list of speakers including UMass Memorial Medical Center President Dr. Michael Gustafson and Congressman Jim Mcgovern (D-Worcester).
WBJ Web Partners
Most Recent
Most Recent
0 Comments